LSE-AIM$RNLXY
Renalytix Plc · Q4 2024 earnings
Q4 2024 earnings · · Investor relations
Briefing
RNLXY Q4 2024 — £50.0M revenue
These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, levels of activity, performance or achievements to be materially differen. Renalytix Plc reported Q4 2024 results. Net income of £33.5M. Headline numbers extracted from the Form 10-K press release; narrative is light because this row was processed without an LLM call.
- Revenue: £50.0M.
- Net income: £33.5M.
- Operating income: £30K.
- Gross profit: £156.
Headline financials
Revenue & EPS history
Renalytix · Revenue · Quarterly
$464K
Revenue by segment
Renalytix · $1.2M total across 2 segments · Q2 2023
- KidneyIntelX$1M—83.3%
- Pharmaceutical Services$200K—16.7%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 16 quarterly earnings reports · overlaid with Q4 2024
-11.1%
Avg return
Earnings day
-16.1%
Avg return
5 days after
-20.5%
Avg return
30 days after
19%
3 / 16 earnings
Positive
+13.8%
Q1 2023
Best reaction
-37.4%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2024 | -8.1% | -25.2% | -40.5% | |
| Q1 2025 | -8.1% | -25.2% | -40.5% | |
| Q3 2024 | -4.1% | -22.4% | -23.6% | |
| Q2 2024 | -37.4% | -38.0% | -28.9% | |
| Q1 2024 | +3.3% | -16.9% | -34.4% | |
| Q4 2023 | -21.9% | -17.9% | -44.4% | |
| Q2 2023 | -21.9% | -17.9% | -44.4% | |
| Q3 2023 | -5.7% | -3.2% | +46.3% | |
| Q1 2023 | +13.8% | +16.0% | -0.5% | |
| Q4 2022 | +6.7% | -10.2% | +21.6% | |
| Q3 2021 | -37.3% | -41.3% | -37.5% | |
| Q3 2022 | -37.3% | -41.3% | -37.5% | |
| Q2 2022 | -9.1% | -2.3% | -20.0% | |
| Q1 2022 | -9.1% | -2.3% | -20.0% | |
| Q4 2021 | -0.7% | -3.9% | -26.2% | |
| Q4 2020 | -0.8% | -6.0% | +1.9% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro